IceCure Announces Pricing of $4.0 Million Registered Direct Offering and Concurrent Private Placement
CAESAREA, Israel, March 26, 2026 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an option to surgical tumor removal, today announced that it...
CP
cision pr newswire
via Pr Newswire
Updated 3h ago

Source Verification
Corroboration Score: 1This story was independently reported by 1 sources. Click any source to read the original article.
Comments
0 commentsBe respectful and constructive.
Loading comments...
Previous
Barking up a whole new timeline: 16,000-year-old dog DNA unleashes a twist in the origin story of humanity’s first best friend
Next
The DJI Avata 360 Aims to Ground Insta360's Drone Dreams
Related Articles
HealthEating The Same Meals Every Day May Have a Surprising Effect on Weight Loss
ScienceAlert-14h ago-1 sources
HealthThe Sudden Death of a Man Who Told Chinese Kids How to Succeed
The New York Times-14h ago-1 sources
HealthHow to Turn a Chicken Egg Into a Drug Factory
The New York Times-14h ago-1 sources